Presence of autoantibody against attr Val30Met after sequential liver transplantation

Transplantation

Volumn 73, Issue 5, 2002, Pages 751-755

  Ando, Yukio ^a   Terazaki, Hisayasu ^a   Haraoka, Katsuki ^a   Tajiri, Takahiro ^a   Nakamura, Masaaki ^a   Obayashi, Konen ^a   Misumi, Shogo ^a   Shoji, Shozo ^a   Hata, Kanako ^a   Nakagawa, Kazuko ^a   Ishizaki, Takashi ^a   Uemoto, Shinji ^a   Inomata, Yukihiro ^a   Tanaka, Koichi ^a   Okabe, Hiroaki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PREALBUMIN;

ADOLESCENT; ADULT; AMYLOID NEUROPATHY; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0037087541     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200203150-00016     Document Type: Article

References (26)

1. Familial amyloid polyneuropathy
2. Transthyretin amyloidosis
3. Transthyretin and familial amyloidotic polyneuropathy
4. Type 1 familial amyloidotic polyneuropathy
5. Liver transplantation as a treatment for familial amyloidotic polyneuropathy
6. Partial-liver transplantation to treat familial amyloid polyneuropathy: Follow-up of 11 patients
7. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I
8. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy
9. Liver transplantation in transthyretin familial amyloid polyneuropathy: First report from Argentina
10. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
11. New structural information and update on liver transplantation in transthyretin-associated amyloidosis: Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umea, Sweden, June 1999
12. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation
13. Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy
14. Familial amyloidotic polyneuropathy: Domino liver transplantation
15. Reuse of a Japanese familial amyloidotic polyneuropathy patient's liver for a cancer patient: The domino liver transplantation procedure
16. Sequential orthotopic liver transplantation: Domino transplantation
17. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease: Possible association with a steroid-resistant transplant rejection episode
18. Enzyme-linked immunosorbent assay of transthyretin devised for semimicro plasma diagnosis of familial amyloidotic polyneuropathy
19. Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: Effects on detection and quantification
20. A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels
21. The p2 gag peptide, AEAMSQVTNTATIM, processed from HIV-1 Pr55 gag was found to be a suicide inhibitor of HIV-1 protease
22. Down-regulation of a harmful variant protein by replacement of its normal protein
23. A new simple and rapid screening method for variant transthyretin-related amyloidosis
24. Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid
25. Nucleotide analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy
26. Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis